Buée L - Search Results

1

[Biological markers in Alzheimer disease: what are the chances for less slow diagnosis?].

Schraen-Maschke S, Dhaenens CM, Bombois S, Deramecourt V, Van Brussel E, Obriot H, Marzys C, Sergeant N, Maurage CA, Pasquier F, Sablonnière B, Buée L. Schraen-Maschke S, et al. Among authors: buee l. Rev Neurol (Paris). 2009 Apr;165 Spec No 2:F97-103. Rev Neurol (Paris). 2009. PMID: 19593884 Review. French. No abstract available.

2

Specific pathological Tau protein variants characterize Pick's disease.

Delacourte A, Robitaille Y, Sergeant N, Buée L, Hof PR, Wattez A, Laroche-Cholette A, Mathieu J, Chagnon P, Gauvreau D. Delacourte A, et al. Among authors: buee l. J Neuropathol Exp Neurol. 1996 Feb;55(2):159-68. doi: 10.1097/00005072-199602000-00004. J Neuropathol Exp Neurol. 1996. PMID: 8786374

3

Two-dimensional characterization of paired helical filament-tau from Alzheimer's disease: demonstration of an additional 74-kDa component and age-related biochemical modifications.

Sergeant N, David JP, Goedert M, Jakes R, Vermersch P, Buée L, Lefranc D, Wattez A, Delacourte A. Sergeant N, et al. Among authors: buee l. J Neurochem. 1997 Aug;69(2):834-44. doi: 10.1046/j.1471-4159.1997.69020834.x. J Neurochem. 1997. PMID: 9231745 Free article.

4

Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes.

Mailliot C, Sergeant N, Bussière T, Caillet-Boudin ML, Delacourte A, Buée L. Mailliot C, et al. Among authors: buee l. FEBS Lett. 1998 Aug 21;433(3):201-4. doi: 10.1016/s0014-5793(98)00910-7. FEBS Lett. 1998. PMID: 9744794 Free article.

5

The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.

Delacourte A, David JP, Sergeant N, Buée L, Wattez A, Vermersch P, Ghozali F, Fallet-Bianco C, Pasquier F, Lebert F, Petit H, Di Menza C. Delacourte A, et al. Among authors: buee l. Neurology. 1999 Apr 12;52(6):1158-65. doi: 10.1212/wnl.52.6.1158. Neurology. 1999. PMID: 10214737

6

Rapid tau protein dephosphorylation and differential rephosphorylation during cardiac arrest-induced cerebral ischemia and reperfusion.

Mailliot C, Podevin-Dimster V, Rosenthal RE, Sergeant N, Delacourte A, Fiskum G, Buée L. Mailliot C, et al. Among authors: buee l. J Cereb Blood Flow Metab. 2000 Mar;20(3):543-9. doi: 10.1097/00004647-200003000-00013. J Cereb Blood Flow Metab. 2000. PMID: 10724119

7

Pathological tau phenotypes. The weight of mutations, polymorphisms, and differential neuronal vulnerabilities.

Mailliot C, Bussière T, Hamdane M, Sergeant N, Caillet ML, Delacourte A, Buée L. Mailliot C, et al. Among authors: buee l. Ann N Y Acad Sci. 2000;920:107-14. doi: 10.1111/j.1749-6632.2000.tb06911.x. Ann N Y Acad Sci. 2000. PMID: 11193138

8

[Tau story: from frontotemporal dementia to other tauopathies].

Buée L, Hamdane M, Delobel P, Sambo AV, Bégard S, Ghestem A, Sergeant N, Delacourte A. Buée L, et al. J Soc Biol. 2002;196(1):103-8. J Soc Biol. 2002. PMID: 12134624 Review. French.

9

Abnormal Tau phosphorylation of the Alzheimer-type also occurs during mitosis.

Delobel P, Flament S, Hamdane M, Mailliot C, Sambo AV, Bégard S, Sergeant N, Delacourte A, Vilain JP, Buée L. Delobel P, et al. Among authors: buee l. J Neurochem. 2002 Oct;83(2):412-20. doi: 10.1046/j.1471-4159.2002.01143.x. J Neurochem. 2002. PMID: 12423251 Free article.

10

Pin1: a therapeutic target in Alzheimer neurodegeneration.

Hamdane M, Smet C, Sambo AV, Leroy A, Wieruszeski JM, Delobel P, Maurage CA, Ghestem A, Wintjens R, Bégard S, Sergeant N, Delacourte A, Horvath D, Landrieu I, Lippens G, Buée L. Hamdane M, et al. Among authors: buee l. J Mol Neurosci. 2002 Dec;19(3):275-87. doi: 10.1385/JMN:19:3:275. J Mol Neurosci. 2002. PMID: 12540053

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

337 results

Search Page